Carla D Loyola
Overview
Explore the profile of Carla D Loyola including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
3
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hernandez I, Gobinath C, Padilla A, Loyola C, Joddar B
Res Sq
. 2025 Jan;
PMID: 39764116
This study aimed to elucidate the impact of advanced glycation end products (AGEs) and glucose shock on cardiomyocyte viability, gene expression, cardiac biomarkers, and cardiac contractility. Firstly, AGEs were generated...
2.
Ramirez S, Hernandez I, Dorado Z, Loyola C, Roberson D, Joddar B
ACS Omega
. 2024 Sep;
9(35):37063-37075.
PMID: 39246477
Parkinson's disease (PD), a progressive central nervous system disorder marked by involuntary movements, poses a significant challenge in neurodegenerative research due to the gradual degeneration of dopaminergic (DA) neurons. Early...
3.
Hernandez I, Ramirez S, Salazar W, Mendivil S, Guevara A, Patel A, et al.
Bioengineering (Basel)
. 2023 Jul;
10(7).
PMID: 37508861
In this study, we designed a tissue-engineered neurocardiac model to help us examine the role of neuronal regulation and confirm the importance of neural innervation techniques for the regeneration of...
4.
El Khoury R, Ramirez S, Loyola C, Joddar B
RSC Adv
. 2023 Mar;
13(12):8338-8351.
PMID: 36922946
Doxorubicin (DOX) is a highly effective anthracycline chemotherapy agent effective in treating a broad range of life-threatening malignancies but it causes cardiotoxicity in many subjects. While the mechanism of its...
5.
Joddar B, Loyola C, Ramirez S, Singh I
Biochem Biophys Res Commun
. 2023 Feb;
648:72-80.
PMID: 36736094
Hyperglycemia-mediated cardiac dysfunction is an acute initiator in the development of vascular complications, leading to cardiac fibrosis. To investigate the effects of hyperglycemia-mediated changes in cardiomyocytes, cells were cultured in-vitro...